Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialShaji Kumar, Philippe Moreau, Kenshi Suzuki et al.|The Lancet Oncology|2020Cited by 401
Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stressKenshi Suzuki, Koji Tsuboi|Neuro-Oncology|2013Cited by 76
Vox Sanguinis International Forum on typing and matching strategies in patients on anti‐<scp>CD</scp>38 monoclonal therapy: summaryKaren M. K. de Vooght, Ratti Ram Sharma, Miquel Lozano et al.|Vox Sanguinis|2018Cited by 5
International Forum on typing and matching strategies in patients on anti‐<scp>CD</scp>38 monoclonal therapyKaren M. K. de Vooght, Ratti Ram Sharma, Miquel Lozano et al.|Vox Sanguinis|2018Cited by 2